PEOPLE - SurModics makes appointment:
This article was originally published in Clinica
Executive Summary
Surface modification and drug delivery solutions technology and products provider SurModics (Eden Prairie, Minnesota) has appointed president and COO Bruce Barclay to the post of CEO, effective from July 1. He replaces Dale Olseth, who will become executive chairman. Mr Barclay's priority will be to drive the growth strategy of the company. He has over 25 years with leading healthcare companies, and has served with SurModics since December 2003.